Skip to product information

Tirzepatide (10mg)

Tirzepatide (10mg)

Regular price $149.99
Regular price $149.99 Sale price
SAVE Sold out
Tirzepatide (10mg)

Tirzepatide (10mg)

Regular price $149.99
Regular price $149.99 Sale price
SAVE Sold out

Tirzepatide is a synthetic peptide that functions as a dual agonist of the GIP and GLP-1 receptors. It has been studied in laboratory research for its interaction with multiple incretin receptor pathways and is recognized for its structural stability and consistency in experimental settings. Supplied as a high-purity research compound, Tirzepatide is intended for controlled scientific investigation into peptide activity and receptor signaling.

Disclaimer: This peptide is intended for laboratory research use only. It is not approved for human consumption, therapeutic, or diagnostic applications.

  • local_shipping Fast Shipping
  • 99% Purity
  • factory Made in USA
View full details

What is Tirzepatide?

Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist developed for laboratory research into incretin hormone pathways. This research compound allows scientists to study both receptor systems simultaneously in controlled experimental environments. Scientific investigations have documented its molecular interactions with pancreatic signaling, glucose homeostasis mechanisms, and metabolic pathway regulation, making it a valuable tool for understanding dual incretin receptor interactions in experimental research applications.

Chemical Structure of Tirzepatide

Tirzepatide is a synthetic dual incretin receptor agonist with the amino acid sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS. The compound incorporates non-proteinogenic amino acid residues (Aib: aminoisobutyric acid) and fatty acid modifications that enhance stability and extend half-life in experimental protocols. With a molecular formula of C₂₂₅H₃₄₈N₄₈O₆₈ and molecular weight of 4813.527 g/mol (PubChem CID: 156588324, CAS: 2023788-19-2), this research peptide demonstrates unique structural characteristics for investigating dual GIP/GLP-1 receptor pathway interactions. The peptide's synthetic modifications, including the C20 fatty acid conjugation, provide enhanced bioavailability and stability for extended laboratory research applications across various experimental conditions.